Concepedia

Patient preference of ranibizumab treatment regimen for neovascular age-related macular degeneration — monthly injections versus pro re nata

Katharina M. Droege, Albert Caramoy, Andreas Kersten, Janina Luberichs-Fauser, Katharina Zilkens, Dirk Müller, Bernd Kirchhof, Sascha Fauser

Graefe s Archive for Clinical and Experimental Ophthalmology · 2013 · 33 citations · 5 references

DOI

Concepts

References

5

Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration

Daniel Martín, Maureen G. Maguire, Stuart L. Fine et al. · Ophthalmology · 2012 · 1.7K citations · Full text

, , +12

Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration

Usha Chakravarthy, Simon Harding, Chris Rogers et al. · Ophthalmology · 2012 · 777 citations

, , +11

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2

Prema Abraham, Huibin Yue, Laura Wilson · American Journal of Ophthalmology · 2010 · 443 citations

, , +10

Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real life

Katharina M. Droege, Philipp S. Muether, Manuel M. Hermann et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2012 · 115 citations

, , +9

Long-term effects of ranibizumab treatment delay in neovascular age-related macular degeneration

Philipp S. Muether, Robert Hoerster, Manuel M. Hermann et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2012 · 86 citations

, , +12